GFACX | MRLTX | GFACX / MRLTX | |
Total Expense Ratio | 1.36 | 1.00 | 136% |
Annual Report Gross Expense Ratio | 1.36 | 1.11 | 123% |
Fund Existence | 24 years | 16 years | - |
Gain YTD | 11.794 | 6.383 | 185% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2000 | 13% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 325B | 138M | 235,507% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 11.69 | 4.00 | 293% |
Returns for 3 years | 47.52 | 26.57 | 179% |
Returns for 5 years | 34.11 | 36.03 | 95% |
Returns for 10 years | 67.13 | 66.96 | 100% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MIDLX | 34.45 | 0.19 | +0.55% |
MFS International New Discovery R6 | |||
RMATX | 11.42 | 0.04 | +0.35% |
Russell Inv Multi-Asset Strat M | |||
RYMSX | 24.54 | 0.03 | +0.12% |
Guggenheim Multi-Hedge Strategies P | |||
DPLGX | 28.23 | -0.03 | -0.11% |
Jackson Square Large-Cap Growth IS | |||
LGOAX | 41.95 | -0.05 | -0.12% |
Patient Opportunity A |